Solriamfetol and CBT-I in Patients With Insomnia Disorder

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
Medication is FDA approved. The objective of this project is to test the efficacy of solriamfetol for treating insomnia (alone and in combination with Cognitive Behavioral Therapy for Insomnia \[CBT-I\]). Ultimately, this study will test whether wake extension (regardless of how it is achieved) will consolidate sleep and improve sleep continuity.
Epistemonikos ID: 61db1e875642eac637bb4e7166a8be844583ddee
First added on: Feb 19, 2024